Literature DB >> 3876946

Differentiation between idiopathic pulmonary fibrosis and interstitial pneumonia associated with collagen vascular diseases by comparison of the ratio of OKT4+ cells and OKT8+ cells in BALF T lymphocytes.

S Nagai, N Fujimura, T Hirata, T Izumi.   

Abstract

Idiopathic pulmonary fibrosis (IPF) and interstitial pneumonia associated with collagen vascular disease have been shown to be difficult to differentiate by clinical, roentgenological, pathological and immunological findings. We have applied the analysis of BALF T cell phenotypes to these two groups by enumerating the cell populations of OKT4+ and OKT8+ cells in BALF and, as a result, have been able to discern a clear and meaningful differentiating point between the two groups. In all 9 patients with IPF were examined in whom OKT4+ cells outnumbered OKT8+ cells in BALF T cell subsets, while 13 patients with collagen vascular disease were tested (3 SLE, 6 RA, 2 Sjögren's syndrom and 2 MCTD) in whom OKT8+ cells were more numerous than OKT4+ cells. No difference was observed in blood T lymphocytes between these two groups. These results provide us with a means of differentiation between these groups, especially in clinically borderline cases.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3876946

Source DB:  PubMed          Journal:  Eur J Respir Dis        ISSN: 0106-4339


  7 in total

1.  In vivo levels and in vitro production of interferon-gamma in fibrosing interstitial lung diseases.

Authors:  C Prior; P L Haslam
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

Review 2.  Subclinical alveolitis in immunologic systemic disorders.

Authors:  B Wallaert
Journal:  Lung       Date:  1990       Impact factor: 2.584

3.  Expression of class II MHC antigens on alveolar epithelium in fibrosing alveolitis.

Authors:  C G Kallenberg; B M Schilizzi; F Beaumont; S Poppema; L De Leij; T H The
Journal:  Clin Exp Immunol       Date:  1987-01       Impact factor: 4.330

4.  In vitro production of B cell growth factor and B cell differentiation factor by peripheral blood mononuclear cells and bronchoalveolar lavage T lymphocytes from patients with idiopathic pulmonary fibrosis.

Authors:  M Emura; S Nagai; M Takeuchi; M Kitaichi; T Izumi
Journal:  Clin Exp Immunol       Date:  1990-10       Impact factor: 4.330

5.  Efficacy of cyclosporin A for idiopathic pulmonary fibrosis.

Authors:  M Fukazawa; M Kawano; S Hisano; K Ueda; K Matsuba
Journal:  Eur J Pediatr       Date:  1990-03       Impact factor: 3.183

6.  Characterization of IL-1 inhibitory factor released from human alveolar macrophages as IL-1 receptor antagonist.

Authors:  M Takeuchi; S Nagai; H Nakada; H Aung; N Satake; H Kaneshima; T Izumi
Journal:  Clin Exp Immunol       Date:  1992-04       Impact factor: 4.330

7.  Interstitial pulmonary fibrosis with and without associated collagen vascular disease: results of a two year follow up.

Authors:  C Agustí; A Xaubet; J Roca; A G Agustí; R Rodriguez-Roisin
Journal:  Thorax       Date:  1992-12       Impact factor: 9.139

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.